Drug Database
Back to search

Belgium· BE-AMP-SAM140253-00

Losferron 695 mg

A ferrous gluconate product containing ferrous gluconate, registered in Belgium by Grunenthal. The same ATC class is registered in 5 of our 19 countries.

ATC B03AA03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLosferron 695 mgATCB03AA03REGISTER NO.BE-AMP-SAM140253-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ferrous gluconateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ferrous gluconate is registered in 5 of 19 countries.

Countries holding a registration under ATC B03AA03 (ferrous gluconate), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search ferrous gluconate products by name

Ferrous gluconate · ATC B03AA03

5 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Italyprice
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ferrous gluconate costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ferrous gluconate · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • IT Italy$0.54
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ferrous Gluconate
Manufacturer
Grunenthal
Country
Belgium (BE)
ATC code
B03AA03
ATC class
Ferrous gluconate
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0604645
  • be_apb
    0381673

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

79 interactions on record for ferrous gluconate.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ferrous gluconate against other medicinesHow interaction checks work

Ferrous gluconate · interactions on record

79 records

  • 3 severe
  • 69 moderate
  • 7 minor

Most severe, free to view

  • DolutegravirJ05AJ03severe
  • DolutegravirJ05AX12severe
  • DimercaprolV03AB09severe
  • Magnesium carbonateA02AA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ferrous gluconate in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ferrous gluconate products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Cyprus · Ferrous Gluconate Remedica
  • Germany · Eisen, Floradix Mit Eisen
  • Spain · Losferron
  • United Kingdom (Northern Ireland) · Ferrous Gluconate, Ferrous Gluconate Bp Farmak Pharmaceuticals Uk
  • Greece · Acifer, Fer De Far
  • Italy · Ferro Complex, Ferro Gluconato Eg
  • Luxembourg · Losferron
  • Malta · Ferrous Gluconate
  • Netherlands · Losferron
  • Poland · Ascofer
  • Portugal · Bioferro

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e3d91f8b-480c-494f-b393-4b299b6c9c4f
GET /v1/drugs/e3d91f8b-480c-494f-b393-4b299b6c9c4f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Effervescent tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Losferron 695 mg",
  "name_fr": "Losferron 695 mg",
  "name_nl": "Losferron 695 mg",
  "amp_code": "SAM140253-00",
  "strengths": [
    "695.0000",
    "695.0000",
    "80.5000",
    "80.5000",
    "2.0000",
    "2.0000",
    "5.0000",
    "150.0000",
    "80.0000",
    "563.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Ferrous Gluconate",
    "Iron Divalent",
    "E 110",
    "Saccharin Sodium",
    "Sodium Carbonate Anhydrous",
    "Sodium Cyclamate",
    "Sodium Hydrogen Carbonate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ferrous Gluconate",
  "authorisation_numbers": [
    "BE140253",
    "BE158313"
  ]
}
API referenceMCP serverPlans

See everything about ferrous gluconate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console